METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
Authors
Keywords
Glioma, RNA modification, METTL3, LncRNA, NF-κB
Journal
CANCER LETTERS
Volume 511, Issue -, Pages 36-46
Publisher
Elsevier BV
Online
2021-04-30
DOI
10.1016/j.canlet.2021.04.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
- (2020) Rui-Chao Chai et al. Acta Neuropathologica Communications
- RNA modifications in brain tumorigenesis
- (2020) Albert Z. Huang et al. Acta Neuropathologica Communications
- Mechanism of RNA modification N6-methyladenosine in human cancer
- (2020) Zijian Zhou et al. Molecular Cancer
- m6A modification in RNA: biogenesis, functions and roles in gliomas
- (2020) Yuhao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
- (2020) Yu-Zhou Chang et al. Frontiers in Cell and Developmental Biology
- Clinical practice guidelines for the management of adult diffuse gliomas
- (2020) Tao Jiang et al. CANCER LETTERS
- IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65
- (2019) Bin Wang et al. CANCER LETTERS
- Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
- (2019) David J. Voce et al. CANCER RESEARCH
- Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma
- (2019) Rui-Chao Chai et al. CARCINOGENESIS
- Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
- (2019) Kai Huang et al. Advanced Science
- N6-methyladenosine Modulates Nonsense-mediated mRNA Decay in Human Glioblastoma
- (2019) Fuxi Li et al. CANCER RESEARCH
- m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
- (2019) Dan Jin et al. Journal of Hematology & Oncology
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
- (2018) Ying Yang et al. CELL RESEARCH
- Multiple functions of m6A RNA methylation in cancer
- (2018) Yutian Pan et al. Journal of Hematology & Oncology
- m6A RNA Methylation Controls Neural Development and Is Involved in Human Diseases
- (2018) Kunzhao Du et al. MOLECULAR NEUROBIOLOGY
- Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
- (2018) Qixue Wang et al. Theranostics
- Integrated molecular characterization of IDH -mutant glioblastomas
- (2018) A. Korshunov et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression
- (2018) Subbarayalu Panneerdoss et al. Science Advances
- PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
- (2018) Zuoxin Zhang et al. CANCER LETTERS
- Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
- (2017) A Visvanathan et al. ONCOGENE
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- CGCG clinical practice guidelines for the management of adult diffuse gliomas
- (2016) Tao Jiang et al. CANCER LETTERS
- N6-methyladenosine–encoded epitranscriptomics
- (2016) Nian Liu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling
- (2016) Y Han et al. Cell Death & Disease
- N6-methyladenosine–encoded epitranscriptomics
- (2016) Nian Liu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
- (2015) I Vassallo et al. ONCOGENE
- Fate by RNA methylation: m6A steers stem cell pluripotency
- (2015) Boxuan Zhao et al. GENOME BIOLOGY
- Gene expression regulation mediated through reversible m6A RNA methylation
- (2014) Ye Fu et al. NATURE REVIEWS GENETICS
- AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries
- (2013) Rui Chao Chai et al. GLIA
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Grand Challenge Commentary: RNA epigenetics?
- (2010) Chuan He Nature Chemical Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started